ArticleScientific reports2018
Publisher Correction: Chimeric peptide EP45 as a dual agonist at GLP-1 and NPY2R receptors.
Oleg G Chepurny et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ArticleScientific reports2018
Oleg G Chepurny et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.